iBio, Inc. Form 8-K Summary
Business Context and Reporting Period
iBio, Inc. (Nasdaq: IBIO), a Delaware corporation headquartered in San Diego, California, filed this Current Report on Form 8-K on August 28, 2026. The filing serves to announce the Company's financial results for the fiscal year ended June 30, 2026.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document references a press release (Exhibit 99.1) containing these details but does not reproduce the data within the 8-K text itself.
Material Changes
No material changes versus the prior comparable period are detailed in the provided text. The filing solely references the issuance of the annual results press release.
Guidance, Outlook, and Risks
The filing includes standard legal disclaimers stating that the information in Item 2.02 and the attached press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other SEC filings. No specific guidance, outlook, or risk factors are enumerated in the text provided.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 28, 2026) for specific fiscal year 2026 financial figures.
- Verify the Company's cash position and burn rate given the lack of explicit liquidity data in the 8-K summary.
- Confirm any forward-looking statements or guidance provided in the full press release.
- Check for any unusual items or contingencies disclosed in the full financial statements referenced by the press release.